NEOGLIP 50/500MG TAB

NEOGLIP 50/500MG is a combination tablet containing Sitagliptin 50mg and Metformin 500mg. This dual-action medication is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Sitagliptin works by increasing insulin secretion in response to elevated blood glucose levels, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Together, they provide effective glycemic control for patients with type 2 diabetes mellitus. NEOGLIP is indicated for use in adults when diet and exercise alone are insufficient to manage blood sugar levels. It may be used as monotherapy or in combination with other antidiabetic agents as prescribed by your healthcare provider. Always take this medication as directed by your doctor. Store in a cool, dry place away from moisture and direct sunlight.